Search

everythinglearnresearchcommunity

for

Search:↓

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

More research is needed to understand and treat morphea effectively.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Trichoscopy can help diagnose and decide when to biopsy folliculotropic mycosis fungoides.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

TCM is an effective and safe treatment for primary cicatricial alopecias.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Baricitinib works better than methotrexate for severe alopecia areata.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

The patient has frontal fibrosing alopecia (FFA).

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Patients need better information about the risks of long-term steroid use.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.